Janet Chiang
Endocrinology, Diabetes & Metabolism · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Office
- 1
Offices
1 location
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Janet Chiang’s office at (415) 234-3960 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A123449 · Current
Licensed to practise in California · since 2012 · expires 2028-11-30 · Yale University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$13,707
Pharmacies billed $13,707 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 21) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
0 generic and 13 brand-name prescriptions · $13,707 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 21 | None | 0% (0) | 62% | $13,707 |
| 2023 | 32 | 12 | 0% (0) | 47% | $18,263 |
| 2022 | 174 | 52 | 0% (0) | 61% | $164,927 |
| 2021 | 832 | 119 | 0% (0) | 54% | $499,083 |
| 2020 | 637 | 111 | 0% (0) | 58% | $352,778 |
| 2019 | 361 | 72 | 0% (0) | 59% | $165,102 |
| 2018 | 57 | 23 | 0% (0) | 60% | $9,743 |
| 2017 | 27 | None | 0% (0) | 56% | $3,161 |
| 2016 | 17 | None | 0% (0) | 65% | $3,758 |
| 2015 | 99 | 31 | None | None | $14,910 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 4 drugs
| Forteo | 14 | $67,938 | $4,853 |
| Ozempic | 26 | $42,130 | $1,620 |
| Farxiga | 11 | $6,855 | $623 |
| Methimazole | 13 | $266 | $20 |
2021: 26 drugs
| Ozempic | 89 | $125,537 | $1,411 |
| Forteo | 14 | $61,844 | $4,417 |
| Jardiance | 61 | $56,563 | $927 |
| Victoza 3-Pak | 34 | $48,554 | $1,428 |
| Lantus Solostar | 45 | $29,493 | $655 |
| Victoza 2-Pak | 26 | $22,082 | $849 |
| Trulicity | 17 | $19,966 | $1,174 |
| Novolog Flexpen | 21 | $19,638 | $935 |
| Farxiga | 16 | $15,938 | $996 |
| Humalog Kwikpen U-100 | 16 | $12,523 | $783 |
| Toujeo Solostar | 12 | $12,309 | $1,026 |
| Humalog | 12 | $11,878 | $990 |
| Basaglar Kwikpen U-100 | 22 | $9,587 | $436 |
| Ultra-Fine Mini Pen Needle | 23 | $1,929 | $84 |
| Zoledronic Acid | 13 | $1,765 | $136 |
| Levothyroxine | 48 | $1,505 | $31 |
| Methimazole | 30 | $843 | $28 |
| Hydrocortisone | 15 | $800 | $53 |
| Pioglitazone | 15 | $789 | $53 |
| Glipizide | 60 | $630 | $10 |
| Droplet Pen Needle | 11 | $498 | $45 |
| Metformin Hcl Er | 29 | $359 | $12 |
| Metformin | 48 | $348 | $7 |
| Chlorthalidone | 11 | $239 | $22 |
| Atorvastatin | 11 | $141 | $13 |
| Potassium Chloride | 12 | $74 | $6 |
2020: 18 drugs
| Ozempic | 49 | $74,977 | $1,530 |
| Jardiance | 57 | $52,701 | $925 |
| Forteo | 13 | $49,231 | $3,787 |
| Trulicity | 13 | $23,027 | $1,771 |
| Victoza 3-Pak | 15 | $17,527 | $1,168 |
| Lantus Solostar | 25 | $14,426 | $577 |
| Basaglar Kwikpen U-100 | 24 | $12,155 | $506 |
| Humalog Kwikpen U-100 | 11 | $8,084 | $735 |
| Novolog Flexpen | 12 | $7,394 | $616 |
| Novolog | 11 | $4,172 | $379 |
| Ultra-Fine Mini Pen Needle | 17 | $1,390 | $82 |
| Levothyroxine | 41 | $1,385 | $34 |
| Methimazole | 34 | $854 | $25 |
| Hydrocortisone | 26 | $748 | $29 |
| Chlorthalidone | 20 | $575 | $29 |
| Glipizide | 42 | $248 | $6 |
| Metformin | 20 | $162 | $8 |
| Metformin Hcl Er | 11 | $79 | $7 |
2019: 13 drugs
| Jardiance | 29 | $24,926 | $860 |
| Ozempic | 15 | $17,330 | $1,155 |
| Trulicity | 15 | $13,402 | $893 |
| Toujeo Solostar | 14 | $10,688 | $763 |
| Lantus Solostar | 17 | $9,220 | $542 |
| Novolog Flexpen | 11 | $8,689 | $790 |
| Basaglar Kwikpen U-100 | 23 | $6,821 | $297 |
| Lantus | 11 | $5,482 | $498 |
| Methimazole | 27 | $702 | $26 |
| Levothyroxine | 26 | $580 | $22 |
| Hydrocortisone | 16 | $352 | $22 |
| Metformin | 14 | $283 | $20 |
| Glipizide | 19 | $112 | $6 |
2018: 1 drug
| Levothyroxine | 22 | $602 | $27 |
2017: 1 drug
| Levothyroxine | 14 | $623 | $44 |
Money from drug and device companies
$119 in 2023
| 2023 | 1 | 1 | $119 | $119 |
| 2022 | 1 | 1 | $762 | $762 |
| 2020 | 1 | 1 | None | $31 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Foundation Medicine | None | $119 | 1 payment
|
See the published payment
| Foundation Medicine | Paid to speak or teach · 2023-10-19 | None | $119 |
See earlier years (2022, 2020)
2022: $762
| Bayer HealthCare Pharmaceuticals | Vitrakvi | $762 | 1 payment
|
2020: $31
| Intuitive Surgical | Da Vinci Surgical System | $31 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Abbott Laboratories · Sensor Wear Experiences · 2022 | Their institution | $401 |
Professional record
- NPI
- 1477842458
- Licence
- CA A123449California A123449: Current · expires 2028-11-30
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RE0101X (207RE0101X); Internal medicine (207R00000X)
- Mailing address
- 505 Parnassus Ave, San Francisco, CA, 94143
- NPI first listed
- 2011-03-30
- NPI last updated
- 2021-08-02
- NPI record certified
- 2021-08-02
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.